Skip to main content
OpenTrials

Clinical trial condition

Endocrine System Diseases

Explore clinical trials studying Endocrine System Diseases. Study availability and eligibility vary by location and protocol.

26,764 public trials 3,635 recruiting studies
Refine in advanced search Browse all conditions

Endocrine System Diseases trial results

Recruiting

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

NCT07215559

Conditions
Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +10 more
Locations
  • Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC Gilbert, Arizona, United States
  • Synexus Clinical Research US, Inc. Phoenix, Arizona, United States
  • Pima Heart Tucson, Arizona, United States
  • Precision Clinical Research Sunrise, Florida, United States
View all 42 locations
View Trial Details
Recruiting

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

NCT06725693

Conditions
Adenoma, Adenoma, Islet Cell, Digestive System Diseases, +13 more
Locations
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

Natural History Study of Patients With Excess Androgen

NCT00250159

Conditions
Adrenal Gland Diseases, Adrenal Hyperplasia, Congenital, Adrenal Insufficiency, +21 more
Locations
  • Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

NCT07142252

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Barbara Davis Center for Diabetes Aurora, Colorado, United States
  • University of Florida Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Joslin Diabetes Center Boston, Massachusetts, United States
View all 15 locations
View Trial Details
Recruiting

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

NCT06902376

Conditions
Anaplastic Thyroid Cancer, BRAF Mutation-Related Tumors, Carcinoma, +11 more
Locations
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details

Related conditions